oxidopamine has been researched along with Autism Spectrum Disorder in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
Excerpt | Relevance | Reference |
---|---|---|
"Cannabidivarin (CBDV), a structural analog of cannabidiol (CBD), has received attention in recent years owing to its anticonvulsant property and potential for treating autism spectrum disorder." | 4.31 | Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in Caenorhabditis elegans. ( Jin, S; Jin, T; Li, H; Liu, C; Liu, Y; Long, H; Lu, Y; Peng, Y; Wang, F; Wang, X; Zhao, L, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wang, F | 1 |
Jin, T | 1 |
Li, H | 1 |
Long, H | 1 |
Liu, Y | 1 |
Jin, S | 1 |
Lu, Y | 1 |
Peng, Y | 1 |
Liu, C | 1 |
Zhao, L | 1 |
Wang, X | 1 |
1 other study available for oxidopamine and Autism Spectrum Disorder
Article | Year |
---|---|
Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in Caenorhabditis elegans.
Topics: alpha-Synuclein; Animals; Autism Spectrum Disorder; Caenorhabditis elegans; Caenorhabditis elegans P | 2023 |